All practice questions

8270 questions

Question 1561Question →

A 9-month-old boy is brought to the pediatric emergency department during the winter due to a 3-day history of low-grade fever, rhinorrhea, and worsening cough. Today, his mother noted that he is breathing faster than usual and has been fussy, feeding slightly less than normal. His temperature is 37.9°C (100.2°F), pulse is 145/min, respirations are 56/min, and blood pressure is 90/55 mm Hg. Pulse oximetry shows 94% on room air. On examination, the patient has clear nasal discharge. There are mild subcostal retractions. Lung auscultation reveals diffuse bilateral polyphonic wheezes and scattered coarse crackles. Cardiovascular and abdominal examinations are unremarkable. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Nasal suctioning and oral hydration

Answer

Nasal suctioning and oral hydration
The clinical presentation of a viral prodrome followed by tachypnea, retractions, and polyphonic wheezing in an infant during the winter is classic for acute bronchiolitis, most commonly caused by Respiratory Syncytial Virus (RSV). For infants with bronchiolitis who are well-oxygenated (SpO2 > 90%) and do not have severe respiratory distress (e.g., severe retractions, grunting, lethargy), the cornerstone of therapy is supportive care. Infants are obligate nose breathers, so nasal suctioning is critical to relieve upper airway congestion and reduce work of breathing. Ensuring adequate oral hydration is also essential, as tachypnea and poor feeding can lead to dehydration. Pharmacological interventions have not been shown to change the disease course or improve outcomes in typical cases.

Step-by-Step Solution

1
Identify the clinical syndrome based on the patient's age, symptoms, and physical exam findings.
The patient is an infant presenting in winter with a viral prodrome (rhinorrhea, fever) followed by lower respiratory tract signs (tachypnea, retractions, wheezing, and crackles). This is the classic presentation of acute bronchiolitis, typically caused by Respiratory Syncytial Virus (RSV).
Accurate diagnosis prevents the inappropriate use of medications targeted at other respiratory diseases like asthma or bacterial pneumonia.
2
Assess the severity of the patient's respiratory distress and oxygenation status.
The patient has mild subcostal retractions (mild work of breathing) and a normal oxygen saturation of 94% on room air (no hypoxemia).
Severity dictates the level of intervention required, specifically whether the patient needs supplemental oxygen, intravenous fluids, or hospitalization.
3
Determine the appropriate management strategy for mild-to-moderate acute bronchiolitis.
The appropriate management is purely supportive, prioritizing airway clearance via nasal suctioning and ensuring the infant remains well-hydrated.
Pharmacological interventions (bronchodilators, steroids, antibiotics) do not alter the disease course of viral bronchiolitis and expose the child to unnecessary adverse effects.

Key Concept

The management of mild-to-moderate acute viral bronchiolitis in well-oxygenated infants is supportive, focusing on nasal suctioning and adequate hydration, without the use of bronchodilators, corticosteroids, or antibiotics.
Question 1562Question →

A 45-year-old female patient with newly diagnosed acute myeloid leukemia is currently undergoing induction chemotherapy in the oncology unit. On the tenth day of her treatment course, her body temperature spikes to 38.6°C (101.5°F). Vital signs show a blood pressure of 105/65 mm Hg, a heart rate of 110/min, and respirations of 18/min. She has a tunneled central venous catheter in place. Physical examination reveals no focal signs of infection; her lungs are clear to auscultation, and the catheter site exhibits no erythema or purulent discharge. Laboratory evaluation is notable for a leukocyte count of 400/mm³ with 10% neutrophils, resulting in an absolute neutrophil count of 40/mm³. A diagnosis of high-risk neutropenic fever is established.

Arrange the following clinical steps in the correct chronological sequence for the standard evaluation and management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing high-risk neutropenic fever is: 1) Obtain blood cultures, 2) Initiate empiric antipseudomonal antibiotics, 3) Reassess at 48-72 hours, and 4) Add empiric antifungals if fever persists for 4-7 days.
The management of high-risk neutropenic fever relies on a strict, time-sensitive algorithm to minimize mortality. The sequence begins with identifying the potential pathogen by obtaining blood cultures from all lines to avoid altering the yield of the cultures. Immediately following culture collection, patients must receive broad-spectrum empiric antibiotics that cover Pseudomonas aeruginosa because bacterial infections are the most common and immediately life-threatening complications. At 48-72 hours, the initial regimen is formally reassessed based on the patient's clinical trajectory and preliminary culture results, allowing for de-escalation or targeted adjustments. Finally, if the patient remains persistently febrile after 4-7 days of appropriate antibacterial coverage without an identified source, the likelihood of an invasive fungal infection (such as candidiasis or aspergillosis) rises significantly, which warrants the addition of empiric systemic antifungal therapy.

Step-by-Step Solution

1
Obtain blood cultures
Samples are secured for pathogen identification before drug interference.
Administering antibiotics before drawing cultures can sterilize the blood samples, preventing the identification of the organism and hindering targeted therapy.
2
Administer empiric antipseudomonal antibiotics
Broad-spectrum antibacterial coverage is immediately established.
Neutropenic patients lack the immune response to contain bacterial infections, making rapid initiation of therapy critical for survival.
3
Clinical and microbiological reassessment
Therapy is guided by 48-72 hour culture results and clinical status.
It typically takes 2 to 3 days for bacterial cultures to grow and for the patient to demonstrate a definitive clinical response to the initial empiric regimen.
4
Initiate empiric antifungal therapy
Coverage is expanded to treat potential invasive fungal pathogens.
Persistent fever in a profoundly neutropenic patient after 4 to 7 days of broad-spectrum antibacterial therapy is highly suggestive of an occult fungal infection.

Key Concept

The chronological management of high-risk neutropenic fever requires immediate culture acquisition, followed instantly by antipseudomonal antibacterial therapy, a formal reassessment at 48-72 hours, and the addition of antifungal therapy only if fevers persist beyond 4-7 days.
Estimated Time:1m 30s
Question 1563Question →

Emergency medical responders bring a 5353-year-old male to the emergency department due to severe, acute-onset respiratory distress. The patient's spouse reports he has been unable to sleep lying flat for the past two nights and has been coughing frequently. His medical history is significant for poorly controlled hypertension, type 22 diabetes mellitus, and a 3030-pack-year smoking history. On arrival, he is sitting on the edge of the stretcher, diaphoretic, and using accessory muscles to breathe. Vital signs include a temperature of 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure of 192/108 mmHg192/108\text{ mmHg}, heart rate of 118/min118/\text{min}, and respiratory rate of 30/min30/\text{min}. Pulse oximetry shows an oxygen saturation of 84%84\% on room air. Physical examination reveals prominent jugular venous distention measuring 10 cm H2O10\text{ cm H}_2\text{O} above the sternal angle. Auscultation of the lungs reveals diffuse expiratory wheezes and scattered crackles in the lower two-thirds of both lung fields. A bedside electrocardiogram demonstrates sinus tachycardia with left ventricular hypertrophy but no acute ST-segment changes. Which of the following is the most appropriate initial step in management?

Show answer & explanation

Answer: Intravenous furosemide and noninvasive positive-pressure ventilation

Answer

Intravenous furosemide and noninvasive positive-pressure ventilation
The correct answer addresses both the acute hypoxic respiratory failure and the volume overload defining this patient's acute decompensated heart failure (ADHF). The patient's clinical picture of extreme hypertension, jugular venous distention, orthopnea, crackles, and wheezing represents 'flash' pulmonary edema with cardiac asthma (peribronchial edema). Noninvasive positive-pressure ventilation (NPPV) provides immediate positive end-expiratory pressure, which drives fluid out of the alveoli and significantly reduces both left ventricular preload and afterload. Concurrent administration of an intravenous loop diuretic (like furosemide) provides necessary diuresis to treat the total body volume overload.

Step-by-Step Solution

1
Analyze the patient's presentation and vital signs.
The patient has acute, severe hypoxia (84%84\%), significant hypertension (192/108 mmHg192/108\text{ mmHg}), orthopnea, jugular venous distention, crackles, and wheezing.
Identifying the primary physiological derangement (respiratory failure with severe hypertension and right-sided pressures) is essential for diagnosis.
2
Differentiate between primarily pulmonary (e.g., COPD) and cardiac causes of dyspnea with wheezing.
Despite the smoking history and wheezing, the prominent JVD, orthopnea, and severe hypertension confirm acute decompensated heart failure (ADHF) with 'cardiac asthma', rather than a primary COPD exacerbation.
Cardiac asthma occurs when peribronchial edema causes airway narrowing and wheezing; distinguishing this from true bronchospasm prevents therapeutic errors.
3
Determine the most appropriate initial stabilization step.
The patient requires immediate respiratory support and afterload/preload reduction, best achieved with noninvasive positive-pressure ventilation (NPPV) and an intravenous loop diuretic.
NPPV rapidly improves oxygenation, pushes alveolar fluid into the capillaries, and decreases both preload and afterload. Diuretics remove excess volume.

Key Concept

Patients with acute decompensated heart failure can present with 'cardiac asthma' (wheezing due to peribronchial edema); initial management involves immediate respiratory support with noninvasive positive-pressure ventilation and fluid offloading with loop diuretics.
Estimated Time:1m 0s
Question 1564Question →

A 1919-year-old male college student presents to the emergency department accompanied by his roommate after developing a severe headache, confusion, and high fever over the previous 1212 hours. His temperature is 39.6∘C39.6^\circ\text{C} (103.3∘F103.3^\circ\text{F}), blood pressure is 108/68 mmHg108/68\text{ mmHg}, and heart rate is 118 beats/min118\text{ beats/min}. Physical examination reveals marked nuchal rigidity and a non-blanching petechial rash on his lower extremities. A lumbar puncture is performed, and empiric therapy with intravenous ceftriaxone, vancomycin, and dexamethasone is promptly initiated. Cerebrospinal fluid (CSF) analysis shows a leukocyte count of 3,200 cells/mm33,200\text{ cells/mm}^3 (92%92\% neutrophils), a glucose level of 22 mg/dL22\text{ mg/dL}, and a protein level of 165 mg/dL165\text{ mg/dL}. The following day, the patient's mental status improves. CSF culture grows *Neisseria meningitidis*. Antimicrobial susceptibility testing is pending. Which of the following is the most appropriate next step in this patient's antimicrobial management?

Show answer & explanation

Answer: Stop the vancomycin infusion and maintain the ceftriaxone.

Answer

Stop the vancomycin infusion and maintain the ceftriaxone.
The correct answer is to discontinue the vancomycin infusion and maintain the ceftriaxone. Empiric therapy for acute bacterial meningitis in immunocompetent adults between the ages of 22 and 5050 consists of a third-generation cephalosporin (e.g., ceftriaxone or cefotaxime) plus vancomycin. The sole purpose of adding vancomycin to this empiric regimen is to provide adequate coverage against highly penicillin-resistant strains of *Streptococcus pneumoniae*. Once cerebrospinal fluid cultures definitively identify *Neisseria meningitidis*, the risk of resistant *S. pneumoniae* is eliminated. Antimicrobial stewardship principles strongly dictate that broad-spectrum or additional agents should be discontinued (de-escalated) as soon as culture results allow. *N. meningitidis* is highly susceptible to ceftriaxone, which also boasts excellent central nervous system penetration. Therefore, maintaining ceftriaxone and stopping vancomycin is the most appropriate, targeted management.

Step-by-Step Solution

1
Analyze the patient's presentation and initial management.
The patient presented with classic signs of acute bacterial meningitis and was appropriately started on empiric ceftriaxone, vancomycin, and dexamethasone.
Empiric therapy must cover the most likely pathogens, including highly penicillin-resistant Streptococcus pneumoniae (covered by vancomycin) and Neisseria meningitidis (covered by ceftriaxone).
2
Evaluate the new culture data.
CSF culture has isolated Neisseria meningitidis.
Identifying the specific pathogen allows for targeted therapy, optimizing efficacy while minimizing toxicity and resistance.
3
Determine the appropriate modification to the antibiotic regimen based on stewardship principles.
Vancomycin is no longer needed because the pathogen is not S. pneumoniae. Ceftriaxone alone provides reliable coverage for N. meningitidis.
Discontinuing unnecessary broad-spectrum coverage (de-escalation) is a core component of antimicrobial stewardship.

Key Concept

In patients with acute bacterial meningitis, empiric vancomycin is used specifically to cover penicillin-resistant Streptococcus pneumoniae and should be discontinued once a different pathogen, such as Neisseria meningitidis, is identified.
Question 1565Question →

A 42-year-old woman presents to her primary care physician reporting progressively worsening fatigue and cold intolerance over the past six months. She also notes that her menstrual periods, which were previously regular, ceased entirely eight months ago. Over the last several weeks, she has been experiencing intermittent, dull headaches. She takes no medications and has no significant past medical history.

Physical examination reveals a blood pressure of 110/70110/70 mmHg and a pulse of 5656/min. The thyroid gland is not palpable. Neurologic examination demonstrates delayed relaxation of the deep tendon reflexes. Confrontational visual field testing reveals a loss of peripheral vision in both temporal fields.

Laboratory studies show the following:

Laboratory ParameterPatient ValueReference Range
Prolactin7575 ng/mL4−234 - 23 ng/mL
Thyroid-stimulating hormone (TSH)2.12.1 μ\muU/mL0.4−4.00.4 - 4.0 μ\muU/mL
Free thyroxine (T4)0.50.5 ng/dL0.9−1.70.9 - 1.7 ng/dL
Urine pregnancy testNegativeNegative

Which of the following is the most likely underlying mechanism for this patient's clinical and laboratory findings?

Show answer & explanation

Answer: Disruption of dopaminergic pathways by a suprasellar mass

Answer

The presentation is caused by disruption of dopaminergic pathways by a suprasellar mass (pituitary stalk effect).
The correct answer identifies the 'stalk effect' caused by a non-functioning pituitary macroadenoma. This patient presents with mass effect symptoms (headache, bitemporal hemianopsia) indicating a large sellar lesion. The lesion compresses normal thyrotrophs, causing central hypothyroidism (low Free T4, normal TSH). Simultaneously, it compresses the pituitary stalk (infundibulum). Because prolactin secretion is uniquely regulated by tonic inhibition via hypothalamic dopamine, blocking the stalk prevents dopamine delivery, resulting in a mild elevation of prolactin (usually <100100 ng/mL) and subsequent amenorrhea.

Step-by-Step Solution

1
Interpret the thyroid function tests.
The patient has a low Free T4 (0.50.5 ng/dL) with an inappropriately normal TSH (2.12.1 μ\mu U/mL).
This specific laboratory pattern indicates central (secondary) hypothyroidism, pointing to a pituitary or hypothalamic origin rather than primary thyroid pathology.
2
Analyze the structural and neurological findings.
The patient has new-onset headaches and bitemporal hemianopsia.
These findings are classic for a mass lesion in the sella turcica compressing the optic chiasm, such as a pituitary macroadenoma.
3
Evaluate the prolactin level in the context of the mass lesion.
The prolactin is mildly elevated at 7575 ng/mL.
A prolactinoma large enough to cause visual field deficits would typically produce prolactin levels >200200 ng/mL. A mild elevation suggests the 'stalk effect', where a non-functioning mass compresses the infundibulum, blocking the delivery of inhibitory dopamine from the hypothalamus to the lactotrophs.

Key Concept

Non-functioning pituitary macroadenomas can cause central hypopituitarism (via tissue compression) and mild hyperprolactinemia (via pituitary stalk compression, known as the 'stalk effect').
Question 1566Question →

A 65-year-old man presents to the outpatient clinic with a 4-day history of a productive cough, fevers, and progressively worsening shortness of breath. His medical history is significant for hypertension and type 2 diabetes mellitus, for which he takes lisinopril and metformin. His temperature is 38.4°C (101.1°F), blood pressure is 132/82 mm Hg, pulse is 98/min, and respiratory rate is 22/min. Pulse oximetry shows an oxygen saturation of 94% on room air. Physical examination reveals bronchial breath sounds and crackles in the right lower lung field. A chest radiograph demonstrates a dense consolidation in the right lower lobe. The physician determines the patient is stable for outpatient management. Which of the following is the most appropriate empiric pharmacotherapy for this patient?

Show answer & explanation

Answer: Amoxicillin-clavulanate and azithromycin

Answer

Amoxicillin-clavulanate and azithromycin
The correct answer provides the recommended combination therapy for an outpatient with community-acquired pneumonia (CAP) who has significant medical comorbidities (such as type 2 diabetes mellitus). According to current clinical guidelines, outpatients with comorbidities (e.g., chronic heart, lung, liver, or renal disease; diabetes mellitus; alcoholism; malignancy; or asplenia) require expanded empiric coverage. This is typically achieved with combination therapy consisting of a beta-lactam (such as amoxicillin-clavulanate or cefpodoxime) PLUS a macrolide (such as azithromycin) or doxycycline. Alternatively, monotherapy with a respiratory fluoroquinolone (such as levofloxacin or moxifloxacin) can be used. The beta-lactam provides robust coverage against typical pathogens (e.g., Streptococcus pneumoniae, Haemophilus influenzae), while the macrolide provides coverage against atypical organisms (e.g., Mycoplasma pneumoniae, Chlamydia pneumoniae).

Step-by-Step Solution

1
Diagnose the patient's condition based on clinical presentation.
The patient has community-acquired pneumonia (CAP), evidenced by fever, productive cough, crackles, and a focal lobar consolidation on chest radiograph.
Establishing the correct infectious syndrome is required before selecting empiric antimicrobial therapy.
2
Stratify the patient's risk and determine the appropriate setting of care.
The patient has stable vital signs and oxygenation, permitting outpatient treatment. However, he has significant comorbidities (type 2 diabetes mellitus, hypertension).
The presence of comorbidities alters the expected pathogen profile and resistance patterns, dictating a different empiric antibiotic strategy compared to healthy individuals.
3
Select the appropriate empiric antibiotic regimen for an outpatient with CAP and comorbidities.
The recommended regimen is a beta-lactam (e.g., amoxicillin-clavulanate) combined with a macrolide (e.g., azithromycin) or doxycycline, OR monotherapy with a respiratory fluoroquinolone.
This strategy ensures adequate coverage against common typical pathogens (including macrolide-resistant Streptococcus pneumoniae and beta-lactamase producing Haemophilus influenzae) as well as atypical pathogens (Mycoplasma, Chlamydia, Legionella).

Key Concept

Empiric antibiotic selection for community-acquired pneumonia (CAP) in outpatients with comorbidities
Question 1567Question →

A 5454-year-old man is hospitalized for the initiation of induction chemotherapy for a newly diagnosed high-grade non-Hodgkin lymphoma. Forty-eight hours after starting his chemotherapy regimen, he develops progressive lethargy, generalized muscle cramps, and two episodes of vomiting. His temperature is 37.2∘C37.2^\circ\text{C}, blood pressure is 105/65 mmHg105/65\text{ mmHg}, heart rate is 112/min112\text{/min}, and respiratory rate is 22/min22\text{/min}.

Laboratory studies reveal the following:

Laboratory TestResult
Potassium6.9 mEq/L6.9\text{ mEq/L}
Calcium6.1 mg/dL6.1\text{ mg/dL}
Phosphorus8.8 mg/dL8.8\text{ mg/dL}
Uric acid15.2 mg/dL15.2\text{ mg/dL}
Blood urea nitrogen48 mg/dL48\text{ mg/dL}
Creatinine2.9 mg/dL2.9\text{ mg/dL} (baseline 0.9 mg/dL0.9\text{ mg/dL})

An arterial blood gas analysis reveals a pH of 7.287.28, pCO2\text{pCO}_2 of 30 mmHg30\text{ mmHg}, and HCO3−\text{HCO}_3^- of 14 mEq/L14\text{ mEq/L}. An electrocardiogram demonstrates peaked T waves and a prolonged PR interval. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administer intravenous calcium gluconate, vigorous hydration, and rasburicase

Answer

Administer intravenous calcium gluconate, vigorous hydration, and rasburicase
The correct answer involves immediate cardioprotection with calcium gluconate, followed by aggressive hydration and rasburicase. This patient is presenting with classic Tumor Lysis Syndrome (TLS), an oncologic emergency caused by massive tumor cell destruction following the initiation of cytotoxic therapy. The rapid breakdown of cells releases large amounts of intracellular potassium, phosphorus, and nucleic acids (which are metabolized to uric acid). The resulting hyperphosphatemia leads to secondary hypocalcemia as calcium binds to the excess phosphorus. The patient's electrocardiogram shows critical signs of hyperkalemia (peaked T waves and prolonged PR interval), making intravenous calcium gluconate the absolute most urgent first step to stabilize the cardiac membrane and prevent fatal arrhythmias. This must be given alongside aggressive intravenous hydration to maintain urine output and a potent urate-lowering agent like rasburicase to mitigate further acute kidney injury.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and laboratory results in the context of recent chemotherapy.
The combination of hyperkalemia, hyperphosphatemia, hypocalcemia, hyperuricemia, and acute kidney injury 48 hours after starting chemotherapy points to Tumor Lysis Syndrome (TLS).
High-grade lymphomas are highly responsive to chemotherapy, leading to massive, rapid lysis of tumor cells and release of intracellular contents.
2
Evaluate the patient's electrocardiogram (ECG) and potassium levels.
The potassium is dangerously high (6.9 mEq/L6.9\text{ mEq/L}) with ECG changes (peaked T waves, prolonged PR interval).
ECG changes in the setting of hyperkalemia indicate imminent risk of fatal cardiac arrhythmias.
3
Determine the most appropriate immediate intervention based on the imminent threats to the patient's life.
The immediate priority is myocardial stabilization with intravenous calcium gluconate.
Calcium directly antagonizes the membrane actions of hyperkalemia without lowering the serum potassium level, buying time for therapies that drive potassium into cells or remove it from the body.
4
Identify the definitive management for the underlying pathophysiologic process of TLS.
The patient requires vigorous intravenous hydration and a urate-lowering agent such as rasburicase.
Hydration flushes the renal tubules, and rasburicase rapidly metabolizes existing uric acid into highly soluble allantoin, preventing further uric acid nephropathy and reversing the acute kidney injury.

Key Concept

Diagnosis and management of Tumor Lysis Syndrome (TLS)
Estimated Time:1m 30s
Question 1568Question →

A 34-year-old woman presents to the clinic with a 2-day history of pinpoint red rashes on her lower extremities and bleeding from her gums when brushing her teeth. She reports having a mild upper respiratory infection two weeks ago but is otherwise healthy. She takes no medications and has no personal or family history of bleeding disorders. Vital signs are within normal limits. Physical examination reveals diffuse petechiae over the bilateral shins and ankles. There is no palpable hepatosplenomegaly, and no lymphadenopathy is appreciated. Neurologic examination is unremarkable.

Laboratory results are as follows:
Hemoglobin: 12.5 g/dL12.5 \text{ g/dL}
Leukocyte count: 7,500/mm37,500/\text{mm}^3
Platelet count: 14,000/mm314,000/\text{mm}^3
Prothrombin time: 11 seconds11 \text{ seconds}
Activated partial thromboplastin time: 28 seconds28 \text{ seconds}
Creatinine: 0.8 mg/dL0.8 \text{ mg/dL}

A peripheral blood smear shows enlarged platelets but no schistocytes or blasts. What is the most appropriate next step in management?

Show answer & explanation

Answer: Administer high-dose oral corticosteroids

Answer

Administer high-dose oral corticosteroids
The correct answer is to administer high-dose oral corticosteroids. This patient presents with primary immune thrombocytopenia (ITP), an autoimmune disorder characterized by IgG autoantibodies directed against platelet membrane glycoproteins (e.g., GPIIb/IIIa). This leads to increased platelet destruction by splenic macrophages and isolated thrombocytopenia. The diagnosis is clinical and supported by isolated thrombocytopenia, normal coagulation times, and a peripheral smear showing large platelets (indicating increased bone marrow production) without schistocytes. In adult patients, treatment is indicated if there is active bleeding or if the platelet count is <30,000/mm3< 30,000/\text{mm}^3. First-line therapy consists of high-dose glucocorticoids (such as dexamethasone or prednisone), which may be combined with intravenous immunoglobulin (IVIG) if a rapid increase in platelet count is required.

Step-by-Step Solution

1
Analyze the clinical presentation and laboratory findings.
The patient has isolated thrombocytopenia (14,000/mm314,000/\text{mm}^3) with normal hemoglobin, leukocytes, and coagulation studies. The peripheral smear shows large platelets without schistocytes.
To differentiate between potential causes of thrombocytopenia, such as ITP, TTP, DIC, and bone marrow failure.
2
Establish the most likely diagnosis.
The diagnosis is primary immune thrombocytopenia (ITP), triggered by a recent viral infection.
The isolated low platelet count, mucocutaneous bleeding, lack of splenomegaly, and absence of microangiopathic hemolytic anemia fit the classic presentation of ITP.
3
Determine the indication for treatment.
Treatment is indicated because the platelet count is <30,000/mm3< 30,000/\text{mm}^3 and the patient is experiencing active mucosal bleeding (gums).
Patients with ITP who have platelets <30,000/mm3< 30,000/\text{mm}^3 or significant clinical bleeding are at high risk for severe hemorrhage and require therapy.
4
Select the appropriate first-line therapy.
High-dose glucocorticoids (e.g., dexamethasone or prednisone) are selected.
Corticosteroids reduce autoantibody production and decrease splenic macrophage destruction of antibody-coated platelets, making them the standard initial treatment for ITP.

Key Concept

Diagnosis and management of primary immune thrombocytopenia (ITP)
Estimated Time:1m 0s
Question 1569Question →

A 4242-year-old man is evaluated in the surgical step-down unit due to a sudden deterioration in his clinical status. He was admitted 4848 hours ago for management of an adhesive small bowel obstruction. Initial treatment with intravenous fluids, bowel rest, and nasogastric tube decompression led to mild improvement during the first day. However, over the past 33 hours, his previously intermittent, crampy periumbilical pain has transitioned to severe, constant, and diffuse abdominal pain. Temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), pulse is 128/min128/\text{min}, respirations are 24/min24/\text{min}, and blood pressure is 86/50 mm Hg86/50\text{ mm Hg}. Physical examination reveals a rigid, distended abdomen with marked rebound tenderness and involuntary guarding in all quadrants. Bowel sounds are absent. Laboratory evaluation demonstrates a leukocyte count of 18,500/mm318,500/\text{mm}^3 with 15%15\% band forms, and a serum lactate of 4.8 mmol/L4.8\text{ mmol/L}. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Exploratory laparotomy

Answer

Exploratory laparotomy
The correct answer is exploratory laparotomy. This patient initially presented with an uncomplicated small bowel obstruction (SBO), which is typically managed with bowel rest, intravenous fluids, and nasogastric decompression. However, his clinical picture has drastically changed, indicating progression to a strangulated SBO (ischemia and necrosis of the bowel wall). Classic signs of strangulation include a transition from colicky to severe, constant abdominal pain, fever, tachycardia, and signs of peritonitis (rigidity, rebound tenderness, guarding). The markedly elevated leukocyte count and lactic acidosis further confirm bowel ischemia. In any patient with an acute surgical abdomen, hemodynamic instability, and suspected necrotic bowel, emergent exploratory laparotomy is required to perform a bowel resection and achieve source control.

Step-by-Step Solution

1
Identify the patient's initial diagnosis and current clinical trajectory.
The patient was initially diagnosed with a partial small bowel obstruction but has now acutely deteriorated, developing severe, constant pain.
Tracking symptom progression distinguishes an resolving uncomplicated obstruction from life-threatening complications like bowel ischemia.
2
Analyze vital signs and physical examination findings.
The patient exhibits high fever, tachycardia, hypotension, and a rigid abdomen with severe rebound tenderness.
These findings indicate the development of peritonitis and septic shock.
3
Interpret laboratory results in the context of the clinical picture.
Leukocytosis with a left shift and an elevated serum lactate of 4.8 mmol/L4.8\text{ mmol/L} confirm the presence of bowel ischemia and necrosis.
Lactic acidosis and marked leukocytosis are classic markers for bowel strangulation in the setting of an obstruction.
4
Determine the most appropriate management based on the overall assessment.
Immediate surgical intervention via exploratory laparotomy is required.
Patients with a strangulated small bowel obstruction and peritonitis require emergent resection of the necrotic bowel segment to achieve source control.

Key Concept

Patients with a small bowel obstruction who develop clinical signs of strangulation (fever, tachycardia, severe constant pain, peritonitis, lactic acidosis) require emergent exploratory laparotomy.
Question 1570Question →

A 68-year-old man with a history of severe chronic obstructive pulmonary disease (COPD) is admitted to the intensive care unit for acute hypercapnic respiratory failure and suspected community-acquired pneumonia. Upon arrival, he is hemodynamically stable but exhibits severe respiratory distress. Endotracheal intubation and mechanical ventilation are initiated. Shortly after intubation, his blood pressure drops to 78/45 mmHg and his heart rate increases to 122/min. Pulse oximetry shows 92% on an FiO2FiO_2 of 0.50. Physical examination reveals diffuse wheezing and right lower lobe crackles. A portable chest radiograph demonstrates hyperinflated lungs, a prominent right descending pulmonary artery, and a right lower lobe consolidation, without pulmonary venous congestion. Sputum Gram stain reveals numerous neutrophils and gram-positive, lancet-shaped diplococci. Bedside echocardiography shows a severely dilated right ventricle, a plethoric inferior vena cava, and systolic flattening of the interventricular septum (D-shaped left ventricle); the left ventricular ejection fraction is 65%. Arterial blood gas analysis on current ventilator settings reveals:

ParameterValue
pHpH7.18
PaCO2PaCO_270 mmHg
PaO2PaO_268 mmHg
HCO3−HCO_3^-26 mEq/L

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Initiate a norepinephrine infusion and administer ceftriaxone

Answer

Initiate a norepinephrine infusion and administer ceftriaxone.
The correct answer combines the appropriate hemodynamic support for right ventricular (RV) failure with targeted antimicrobial stewardship. Positive pressure ventilation increases intrathoracic pressure, increasing RV afterload while simultaneously decreasing venous return. In a patient with baseline COPD and pneumonia (which causes hypoxemic pulmonary vasoconstriction), this leads to acute RV failure, manifested by the D-shaped left ventricle (interventricular septal bowing due to RV pressure overload) and obstructive shock. Because RV perfusion is driven by the gradient between the aorta and the RV, profound systemic hypotension causes RV ischemia, worsening the failure in a vicious cycle. Norepinephrine increases systemic mean arterial pressure, restoring the coronary perfusion gradient to the RV. Additionally, the sputum Gram stain specifically identifies *Streptococcus pneumoniae* (gram-positive lancet-shaped diplococci), making targeted therapy with ceftriaxone the most appropriate antimicrobial choice.

Step-by-Step Solution

1
Analyze the hemodynamic and echocardiographic findings.
Hypotension following intubation with a severely dilated right ventricle, plethoric IVC, and a 'D-shaped' left ventricle indicates acute right ventricular failure (cor pulmonale) leading to obstructive shock.
Positive pressure ventilation increases intrathoracic pressure, which increases right ventricular afterload and decreases venous return. In a patient with baseline pulmonary hypertension (COPD), this can acutely precipitate right heart failure.
2
Determine the optimal hemodynamic intervention.
Norepinephrine is indicated to increase systemic vascular resistance and mean arterial pressure.
The failing right ventricle relies heavily on the aortic root pressure (systemic pressure) to maintain its own coronary perfusion gradient. Norepinephrine supports systemic blood pressure without significantly increasing pulmonary vascular resistance.
3
Interpret the sputum Gram stain and select antimicrobial therapy.
Gram-positive, lancet-shaped diplococci indicate Streptococcus pneumoniae. Ceftriaxone provides excellent targeted coverage.
Selecting targeted therapy adheres to antimicrobial stewardship, avoiding unnecessary broad-spectrum agents.

Key Concept

Management of acute right ventricular failure in mechanically ventilated patients requires vasopressors to maintain right coronary perfusion, while avoiding interventions that worsen auto-PEEP or precipitously drop preload.
Estimated Time:2m 30s
Question 1571Question →

An independent 5454-year-old woman is evaluated at a walk-in medical center after experiencing one week of escalating breathlessness. She mentions a newly developed, irritating cough that worsens when she attempts to sleep in her bed, prompting her to sleep propped up in a living room chair. The patient has a known history of essential hypertension and has smoked a pack of cigarettes daily for thirty years. Her vitals indicate a blood pressure of 172/96 mmHg172/96\text{ mmHg}, a pulse of 108/min108\text{/min}, and respirations of 24/min24\text{/min}. Oxygen saturation reads 92%92\% while breathing ambient air. Physical examination reveals distended neck veins when she is seated upright. Auscultating her back reveals widespread crackles at both lung bases that persist despite directed coughing. Cardiac examination is notable for a rapid rate with a clearly audible S3S_3 gallop. Pressing on the skin of her lower legs leaves noticeable indentations bilaterally. Which of the following is the most appropriate initial pharmacologic intervention to relieve this patient's current respiratory symptoms?

Show answer & explanation

Answer: Intravenous furosemide

Answer

Intravenous furosemide is the correct initial pharmacologic intervention.
The correct intervention is intravenous furosemide. This patient is presenting with a classic clinical picture of acute decompensated heart failure (ADHF). She has symptoms of left-sided heart failure (orthopnea, dyspnea, bibasilar lung crackles) and right-sided heart failure (jugular venous distention, lower extremity pitting edema). The presence of an S3S_3 gallop is a highly specific marker for elevated left ventricular filling pressures. Intravenous loop diuretics, such as furosemide, are the first-line pharmacologic therapy to rapidly induce diuresis, decrease intravascular volume, reduce left ventricular preload, and effectively relieve pulmonary congestion and respiratory distress.

Step-by-Step Solution

1
Analyze the patient's symptoms and vital signs.
The patient has progressive dyspnea, orthopnea (sleeping in a chair), hypoxia, tachypnea, and tachycardia.
Identifying the primary clinical syndrome helps narrow down the differential diagnosis between pulmonary and cardiac causes of dyspnea.
2
Evaluate the physical examination findings.
Findings include jugular venous distention, bibasilar crackles, an S3S_3 gallop, and bilateral lower extremity pitting edema.
These are the hallmark signs of left- and right-sided volume overload, confirming a diagnosis of acute decompensated heart failure (ADHF).
3
Determine the most appropriate initial therapy for the diagnosed condition.
Loop diuretics (e.g., intravenous furosemide) are indicated to rapidly reduce volume overload and alleviate pulmonary congestion.
Diuresis directly treats the underlying pathophysiology of ADHF by decreasing left ventricular preload.

Key Concept

The primary initial treatment for acute decompensated heart failure with volume overload (evidenced by orthopnea, JVD, crackles, S3S_3 gallop, and edema) is aggressive diuresis with intravenous loop diuretics.
Question 1572Question →

Primary care evaluation is requested for a 52-year-old male reporting four weeks of profound fatigue, night sweats, and unintentional weight loss. The patient underwent an uncomplicated cystoscopy for benign prostatic hyperplasia two months ago. Vital signs include a temperature of 38.2°C (100.8°F), blood pressure of 118/76 mmHg, and a heart rate of 94/min. Physical examination reveals splinter hemorrhages on the bilateral fingernails and a new grade III/VI holosystolic murmur loudest at the cardiac apex. Transesophageal echocardiography demonstrates a 1.4-cm oscillating mass on the anterior leaflet of the mitral valve. Four out of four blood culture bottles grow *Enterococcus faecalis*. Antimicrobial susceptibility testing reveals the following:

AntimicrobialInterpretation
AmpicillinSusceptible
PenicillinSusceptible
VancomycinSusceptible
Gentamicin (High-Level)Resistant
Streptomycin (High-Level)Resistant

Based on the antimicrobial susceptibility results, which of the following is the most appropriate definitive intravenous antibiotic regimen?

Show answer & explanation

Answer: Ampicillin and ceftriaxone

Answer

Ampicillin and ceftriaxone
The correct answer is ampicillin and ceftriaxone. *Enterococcus faecalis* is a classic cause of infective endocarditis following genitourinary manipulation (such as cystoscopy). Successful treatment requires bactericidal activity. Because ampicillin alone is only bacteriostatic against enterococci, it must be combined with a synergistic agent. Historically, synergy was achieved by combining ampicillin with an aminoglycoside (e.g., gentamicin). However, this patient's isolate demonstrates high-level aminoglycoside resistance (HLAR), meaning aminoglycoside-modifying enzymes completely negate any potential synergy.

To achieve bactericidal activity in HLAR *E. faecalis*, a dual beta-lactam regimen of ampicillin and ceftriaxone is utilized. While enterococci are intrinsically resistant to cephalosporins due to low affinity for specific penicillin-binding proteins (PBPs, primarily PBP5), ampicillin effectively binds PBP4 and PBP5, while ceftriaxone binds PBP2 and PBP3. This complementary saturation of PBPs results in a powerful synergistic bactericidal effect. Notably, because of its equivalent efficacy and lack of nephrotoxicity, ampicillin plus ceftriaxone is now widely considered a first-line therapy for all *E. faecalis* endocarditis cases, even in the absence of HLAR.

Step-by-Step Solution

1
Identify the clinical syndrome
The patient has subacute native valve infective endocarditis, likely seeded from a recent genitourinary procedure.
Establishing the diagnosis determines the requirement for prolonged, bactericidal combination antibiotic therapy.
2
Analyze the microbiologic and susceptibility data
The pathogen is *Enterococcus faecalis*. It is susceptible to beta-lactams (ampicillin, penicillin) but demonstrates high-level resistance to both gentamicin and streptomycin.
To select targeted therapeutic options and rule out ineffective combinations.
3
Evaluate standard treatment protocols in the context of resistance
Standard bactericidal therapy for *E. faecalis* endocarditis historically involves ampicillin plus an aminoglycoside. However, high-level aminoglycoside resistance (HLAR) means synergy is lost, making this combination ineffective.
To prevent the administration of toxic and non-synergistic medications.
4
Select the optimal alternative regimen based on stewardship principles
Ampicillin plus ceftriaxone is selected. This dual beta-lactam regimen provides synergistic bactericidal activity independently of aminoglycoside resistance.
To achieve a targeted, curative outcome while minimizing toxicity and avoiding unnecessarily broad antibiotics like daptomycin.

Key Concept

The definitive treatment of *Enterococcus faecalis* infective endocarditis with high-level aminoglycoside resistance (HLAR) requires dual beta-lactam therapy with ampicillin and ceftriaxone to achieve synergistic bactericidal activity.
Question 1573Question →

During an unscheduled visit to a primary care clinic, a 62-year-old retired teacher reports a 3-day history of progressively worsening shortness of breath and a persistent cough. He notes that his sputum has changed from clear to thick and yellow-green over the past 48 hours. His past medical history is significant for chronic obstructive pulmonary disease (COPD), heart failure with preserved ejection fraction (HFpEF), and Hashimoto thyroiditis. His current medications include inhaled tiotropium, oral metoprolol, and oral levothyroxine.

Vital signs are: temperature 37.9∘C37.9^\circ\text{C} (100.2∘F100.2^\circ\text{F}), blood pressure 138/86 mmHg138/86 \text{ mmHg}, pulse 98/min98/\text{min}, and respirations 24/min24/\text{min}. Oxygen saturation is 89%89\% on room air.

Physical examination reveals a patient in mild respiratory distress. Lung auscultation demonstrates a prolonged expiratory phase with diffuse bilateral wheezing. Cardiac auscultation reveals a regular rhythm with normal heart sounds; there is no jugular venous distention and no peripheral edema.

Arterial blood gas analysis on room air reveals:
pH: 7.347.34
PaCO 2_2: 54 mmHg54 \text{ mmHg}
PaO 2_2: 60 mmHg60 \text{ mmHg}
HCO 3−_3^-: 28 mEq/L28 \text{ mEq/L}

Laboratory studies show a leukocyte count of 11,200/mm311,200/\text{mm}^3, a thyroid-stimulating hormone (TSH) level of 3.5 \muU/mL3.5 \text{ \mu U/mL} (normal: 0.5−5.0 \muU/mL0.5-5.0 \text{ \mu U/mL}), and a free T4 of 1.1 ng/dL1.1 \text{ ng/dL} (normal: 0.8−1.8 ng/dL0.8-1.8 \text{ ng/dL}).

A chest radiograph displays hyperinflated lungs with flattened diaphragms, but no focal consolidation or pleural effusion.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Prescribe oral azithromycin, nebulized albuterol, and a short course of oral prednisone.

Answer

Prescribe oral azithromycin, nebulized albuterol, and a short course of oral prednisone.
The correct answer provides the standard triad of medical therapy for an acute exacerbation of COPD in the outpatient setting. The patient demonstrates the classic presentation of an AECOPD, defined by an acute change in one or more cardinal symptoms: cough, sputum volume, and sputum purulence. Because he has increased sputum purulence along with increased dyspnea, he meets the criteria for antibiotic therapy. Appropriate initial management includes a short-acting bronchodilator (albuterol), a systemic glucocorticoid (oral prednisone for 5-7 days), and a narrow-spectrum oral antibiotic (such as a macrolide like azithromycin, a tetracycline, or a cephalosporin).

Step-by-Step Solution

1
Analyze the patient's presenting symptoms and physical examination findings.
The patient exhibits increased dyspnea, increased cough, and purulent sputum, with diffuse wheezing and hyperinflated lungs.
These are the cardinal signs of an acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
2
Evaluate the arterial blood gas and laboratory values.
The ABG reveals acute-on-chronic respiratory acidosis with hypoxemia. TSH and T4 are normal.
This confirms the severity of the respiratory compromise while ruling out a primary metabolic acid-base disorder or a thyroid abnormality as the cause of his fatigue.
3
Determine the appropriate evidence-based interventions for an outpatient AECOPD with purulent sputum.
The standard of care includes short-acting bronchodilators, systemic glucocorticoids (like oral prednisone), and an oral antibiotic (like azithromycin) due to the presence of all three cardinal symptoms.
Antibiotics are specifically indicated in AECOPD when there is increased sputum purulence combined with at least one other cardinal symptom (increased dyspnea or increased sputum volume).

Key Concept

Management of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) involves bronchodilators, systemic glucocorticoids, and antibiotics (if specific criteria are met).
Question 1574Question →

A 6262-year-old man is evaluated in the emergency department for severe right knee pain that began abruptly during the night. The patient states the pain is so intense that he cannot bear weight or tolerate the bedsheet touching his knee. His past medical history includes hypertension, diet-controlled type 2 diabetes mellitus, and stage 4 chronic kidney disease with a baseline estimated glomerular filtration rate of 22 mL/min/1.73 m222 \text{ mL/min}/1.73 \text{ m}^2. His current medications are amlodipine and atorvastatin. Vital signs show a temperature of 37.6∘C37.6^\circ\text{C} (99.7∘F99.7^\circ\text{F}), blood pressure of 145/88 mm Hg145/88 \text{ mm Hg}, and heart rate of 94/min94/\text{min}. Physical examination reveals a markedly swollen, erythematous, and exquisitely tender right knee. A joint aspiration is performed. Synovial fluid analysis shows a leukocyte count of 42,000/mm342,000/\text{mm}^3 with 82%82\% segmented neutrophils. Gram stain of the fluid demonstrates no organisms. Polarized light microscopy reveals the presence of needle-shaped crystals with strong negative birefringence. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Intra-articular methylprednisolone

Answer

Intra-articular methylprednisolone
The most appropriate management for this patient is an intra-articular injection of a glucocorticoid such as methylprednisolone. The patient is experiencing an acute monoarticular flare of gout, confirmed by the presence of needle-shaped, negatively birefringent crystals in the synovial fluid. While NSAIDs (e.g., indomethacin) and colchicine are typical first-line oral therapies for acute gout, both are highly problematic in this patient due to his stage 4 chronic kidney disease. NSAIDs can precipitate acute renal failure, and colchicine carries a high risk of severe toxicity due to decreased renal clearance. Because only a single joint is involved and infectious arthritis has been reasonably excluded (negative Gram stain), an intra-articular glucocorticoid injection is the safest and most effective option, offering rapid anti-inflammatory action with minimal systemic absorption.

Step-by-Step Solution

1
Analyze the synovial fluid results.
Fluid shows marked leukocytosis with needle-shaped, negatively birefringent crystals and a negative Gram stain.
This definitively confirms the diagnosis of an acute gout flare and makes a concurrent bacterial infection highly unlikely.
2
Evaluate the patient's medical history and comorbidities.
The patient has stage 4 chronic kidney disease (eGFR of 22 mL/min/1.73 m222 \text{ mL/min}/1.73 \text{ m}^2).
Renal function directly dictates the safety profile of standard gout therapies (NSAIDs, colchicine, and systemic glucocorticoids).
3
Select the safest and most effective targeted pharmacotherapy.
Intra-articular glucocorticoids (methylprednisolone) are chosen.
First-line agents like NSAIDs and colchicine are contraindicated in advanced CKD. A local joint injection provides rapid relief with minimal systemic side effects.

Key Concept

Management of acute gout flares in patients with severe chronic kidney disease.
Question 1575Question →

A 28-year-old woman with a 3-year history of systemic lupus erythematosus (SLE) presents to the nephrology clinic with a 2-week history of worsening bilateral lower extremity edema, frothy urine, and new-onset headaches. Her home medications include hydroxychloroquine and naproxen. Her blood pressure is 162/98 mmHg. Physical examination reveals 2+ pitting edema up to the mid-calves and a faint erythematous malar rash. Recent laboratory studies show newly depressed C3 and C4 complement levels and a markedly elevated anti-dsDNA titer. Assuming the patient's clinical condition progresses as expected for a severe renal flare, arrange the following diagnostic and therapeutic steps in the correct chronological sequence for standard management.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Obtain urinalysis/UPCR -> Perform renal biopsy -> Initiate induction therapy -> Transition to maintenance therapy.
The correct chronological management of suspected lupus nephritis begins with non-invasive biochemical confirmation via urinalysis and quantitative protein measurement. Because the histopathologic class of lupus nephritis dictates the necessity and intensity of immunosuppression, a renal biopsy is the mandatory next step prior to initiating aggressive systemic therapy. Once the class is established (e.g., diffuse proliferative lupus nephritis, Class IV), potent induction therapy is initiated to rapidly decrease inflammation. After remission is achieved—typically after 3 to 6 months—the patient is transitioned to a safer maintenance regimen to prevent relapses while avoiding the severe toxicities associated with prolonged induction therapy.

Step-by-Step Solution

1
Assess for biochemical evidence of renal involvement using urinalysis and a spot urine protein-to-creatinine ratio.
Confirms the presence of nephrotic or nephritic syndrome.
Establishes non-invasive proof of lupus nephritis before exposing the patient to the risks of an invasive procedure.
2
Perform a percutaneous renal biopsy.
Classifies the severity and chronicity of the renal lesions (Class I through VI).
Treatment regimens vary drastically based on histologic class; empiric induction is generally avoided without tissue diagnosis due to medication toxicity.
3
Start induction immunosuppression (e.g., high-dose glucocorticoids plus mycophenolate mofetil or cyclophosphamide).
Suppresses acute autoimmune activity and induces clinical remission.
Halts acute inflammatory damage to nephrons in severe proliferative lupus nephritis.
4
Switch to maintenance immunosuppression.
Maintains disease remission with a reduced side-effect profile.
Long-term use of high-dose corticosteroids and full-dose induction agents carries unacceptable risks of infection, malignancy, and metabolic derangements.

Key Concept

The standard management of lupus nephritis requires non-invasive biochemical screening, followed by histologic classification via biopsy, leading to intensive induction therapy and eventual transition to maintenance therapy.
Question 1576Question →

An emergency medicine physician evaluates a 6767-year-old man presenting with a 33-day history of progressively worsening shortness of breath and a change in his chronic cough, now producing yellow sputum.

His past medical history is notable for hypertension, diet-controlled type 2 diabetes mellitus, and a 5050-pack-year smoking history. He has not had any recent hospitalizations.

Physical examination reveals a patient in moderate respiratory distress with a prolonged expiratory phase and diffuse expiratory wheezing. Jugular venous pressure is estimated at 6 cm H2O6\text{ cm H}_2\text{O} (normal: ≤8 cm H2O\le 8\text{ cm H}_2\text{O}). Heart sounds are distant but regular, with no murmurs, rubs, or gallops. There is trace bilateral pedal edema.

A chest radiograph demonstrates hyperlucent lung fields, flattened hemidiaphragms, and an increased retrosternal airspace, without focal consolidations or vascular congestion.

The following laboratory and vital sign data are obtained on presentation:

Vital Signs & Laboratory ParameterValueReference Range
Temperature37.9∘C37.9^\circ\text{C} (100.2∘F100.2^\circ\text{F})36.5−37.3∘C36.5-37.3^\circ\text{C}
Heart rate108/min108/\text{min}60−100/min60-100/\text{min}
Respiratory rate26/min26/\text{min}12−20/min12-20/\text{min}
Blood pressure142/86 mmHg142/86\text{ mmHg}<120/80 mmHg< 120/80\text{ mmHg}
Oxygen saturation89%89\% (on 2 L/min O22\text{ L/min O}_2)≥95%\ge 95\%
Leukocyte count11,500/mm311,500/\text{mm}^34,500−11,000/mm34,500-11,000/\text{mm}^3
Brain natriuretic peptide (BNP)85 pg/mL85\text{ pg/mL}<100 pg/mL< 100\text{ pg/mL}
Arterial pH7.297.297.35−7.457.35-7.45
Arterial PaCO2_262 mmHg62\text{ mmHg}35−45 mmHg35-45\text{ mmHg}
Arterial PaO2_264 mmHg64\text{ mmHg}75−105 mmHg75-105\text{ mmHg}
Arterial HCO3−_3^-29 mEq/L29\text{ mEq/L}22−28 mEq/L22-28\text{ mEq/L}

Which of the following interventions are appropriate for the immediate management of this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Initiation of bilevel positive airway pressure therapy; Administration of systemic methylprednisolone

Answer

The appropriate immediate management steps for this patient are the initiation of bilevel positive airway pressure therapy and the administration of systemic methylprednisolone.
The correct interventions focus on relieving severe bronchospasm, reducing airway inflammation, and reversing acute hypercapnic respiratory failure. Systemic glucocorticoids reduce inflammation and are a standard of care for all severe AECOPD presentations. Bilevel positive airway pressure (BiPAP) is specifically indicated because the patient has developed acute-on-chronic respiratory acidosis (pH ≤7.35\le 7.35 and PaCO 2_2 ≥45 mmHg\ge 45\text{ mmHg}) secondary to alveolar hypoventilation. BiPAP decreases the work of breathing, improves gas exchange, and significantly reduces mortality and the need for invasive mechanical ventilation in this population.

Step-by-Step Solution

1
Identify the primary clinical syndrome based on the patient's presentation and medical history.
The patient is experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) likely triggered by an acute respiratory infection.
The patient has a 5050-pack-year smoking history, prolonged expiratory phase, diffuse wheezing, hyperinflated lungs on chest radiograph, and an acute worsening of dyspnea accompanied by increased purulent sputum production.
2
Interpret the arterial blood gas (ABG) and related diagnostic data.
The ABG reveals an acute-on-chronic respiratory acidosis (pH 7.297.29, PaCO 2_2 62 mmHg62\text{ mmHg}, HCO 3−_3^- 29 mEq/L29\text{ mEq/L}). Furthermore, there is no evidence of concurrent decompensated heart failure (BNP is normal, and chest x-ray lacks vascular congestion).
Determining the severity of the acid-base derangement directly guides the required level of respiratory support.
3
Select evidence-based therapeutic interventions for hypercapnic AECOPD.
Non-invasive positive pressure ventilation (BiPAP), systemic glucocorticoids, inhaled bronchodilators, and targeted antibiotics are indicated.
BiPAP reverses hypercapnic respiratory failure and prevents intubation; systemic steroids significantly reduce airway inflammation and improve recovery time.

Key Concept

Management of severe acute exacerbations of chronic obstructive pulmonary disease (AECOPD) complicated by hypercapnic respiratory acidosis.
Question 1577Question →

A 6262-year-old man is evaluated in the hospital on hospital day 33. He originally presented with a 22-day history of fever, right flank pain, and dysuria. Medical history is significant for nephrolithiasis, for which he underwent a cystoscopy with stent placement 11 week ago.

On admission, temperature was 38.9∘C38.9^\circ\text{C} (102.0∘F102.0^\circ\text{F}), blood pressure was 104/62 mmHg104/62\text{ mmHg}, and pulse was 112/min112/\text{min}. Laboratory studies showed a leukocyte count of 16,500/μL16,500/\mu\text{L}. He was empirically started on intravenous piperacillin-tazobactam.

Today (hospital day 33), his temperature is 37.4∘C37.4^\circ\text{C} (99.3∘F99.3^\circ\text{F}), blood pressure is 122/78 mmHg122/78\text{ mmHg}, and pulse is 84/min84/\text{min}. Blood and urine cultures obtained on admission both grow *Enterobacter cloacae*. Antimicrobial susceptibility testing reveals the following:

* Ampicillin: Resistant
* Cefazolin: Resistant
* Ceftriaxone: Susceptible
* Cefepime: Susceptible
* Piperacillin-tazobactam: Susceptible
* Meropenem: Susceptible

Based on these results, which of the following is the most appropriate next step in the patient's antimicrobial management?

Show answer & explanation

Answer: Transition to intravenous cefepime

Answer

The correct answer is to transition the patient to intravenous cefepime.
The correct next step is to transition the patient to intravenous cefepime. *Enterobacter cloacae* is an organism that intrinsically carries an inducible chromosomal *AmpC* beta-lactamase gene. In the setting of a high initial bacterial burden or invasive infection (such as bacteremia), treating this organism with a third-generation cephalosporin (e.g., ceftriaxone) can rapidly select for derepressed mutants that hyperproduce the AmpC enzyme, leading to subsequent clinical failure despite initial in vitro susceptibility. Cefepime, a fourth-generation cephalosporin, is highly stable against AmpC hydrolysis and is a weak inducer of the enzyme. According to current infectious disease guidelines, cefepime is the preferred definitive therapy for susceptible, high-risk AmpC producers. This choice maximizes clinical efficacy while adhering to antibiotic stewardship principles by sparing carbapenems.

Step-by-Step Solution

1
Analyze the clinical scenario and the microbiological data.
The patient has a urinary-source bacteremia caused by *Enterobacter cloacae*. He is clinically improving on empiric therapy, but definitive targeted therapy is now required based on culture susceptibilities.
Establishing the severity (invasive bacteremia) and the specific pathogen dictates the rules of antibiotic stewardship.
2
Identify the specific resistance mechanisms characteristic of the isolated organism.
*Enterobacter cloacae* is a classic high-risk producer of inducible chromosomal AmpC beta-lactamase.
Organisms with AmpC (like Enterobacter, Klebsiella aerogenes, and Citrobacter freundii) can rapidly develop resistance on therapy even if they initially test susceptible to certain antibiotics.
3
Evaluate the treatment options for an AmpC-producing organism.
Third-generation cephalosporins (ceftriaxone) and piperacillin-tazobactam are associated with clinical failure in invasive AmpC infections despite in vitro susceptibility. Cefepime and carbapenems (meropenem) remain clinically active.
Selecting an antibiotic that will not be hydrolyzed by the AmpC enzyme is critical for patient survival.
4
Apply antimicrobial stewardship principles to select the definitive agent.
Cefepime should be selected over meropenem since the isolate is susceptible to cefepime.
Carbapenems should be spared whenever possible to prevent the emergence of carbapenem-resistant Enterobacteriaceae (CRE). Cefepime provides the optimal balance of targeted efficacy and stewardship.

Key Concept

Definitive treatment of invasive infections caused by high-risk AmpC-producing Enterobacterales (e.g., *Enterobacter cloacae*) requires cefepime (when susceptible) to avoid clinical failure and spare carbapenem use.
Question 1578Question →

A 68-year-old man is evaluated in the hospital on the third day of his admission for community-acquired pneumonia. He originally presented with a 3-day history of fever, productive cough, and shortness of breath. Chest radiography on admission showed a left lower lobe consolidation. He was empirically started on intravenous ceftriaxone and azithromycin. Today, he reports feeling much better and his cough has improved. He has been afebrile for the past 24 hours. His temperature is 37.1°C (98.8°F), blood pressure is 126/82 mm Hg, heart rate is 78/min, and respirations are 16/min. Pulse oximetry is 96% on ambient air. The patient is tolerating a regular diet. Blood cultures obtained on admission are sterile. Sputum culture has grown heavy *Streptococcus pneumoniae*. Susceptibility testing reveals the isolate is sensitive to penicillin, amoxicillin, ceftriaxone, levofloxacin, and vancomycin. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Switch to oral amoxicillin

Answer

Switch to oral amoxicillin
The correct answer is to switch to oral amoxicillin. This patient was admitted with community-acquired pneumonia and appropriately started on an empiric regimen of intravenous ceftriaxone and azithromycin. By hospital day 3, he has met the criteria for clinical stability (afebrile, normal hemodynamics, tolerating oral intake) and is a candidate for transition to oral therapy. Sputum cultures have identified Streptococcus pneumoniae, a typical bacterial pathogen, rendering continued atypical coverage with azithromycin unnecessary. Furthermore, the isolate is sensitive to penicillin. According to the principles of antimicrobial stewardship, antibiotic therapy should be de-escalated to the narrowest effective agent. Oral amoxicillin is the targeted, narrow-spectrum drug of choice for penicillin-susceptible S. pneumoniae.

Step-by-Step Solution

1
Assess the patient's clinical stability for an intravenous-to-oral transition.
The patient is afebrile for 24 hours, hemodynamically stable, has a normal respiratory rate and oxygen saturation, and is tolerating a regular diet.
Patients hospitalized with community-acquired pneumonia should be transitioned to oral antibiotics as soon as they achieve clinical stability and can safely absorb oral medications, in order to facilitate early discharge and reduce catheter-related complications.
2
Evaluate the definitive microbiology and susceptibility results.
Sputum culture confirms an infection by Streptococcus pneumoniae that is fully sensitive to penicillin and amoxicillin.
Empiric broad-spectrum therapy must be de-escalated to a targeted regimen once the causative pathogen and its susceptibility profile are identified.
3
Select the most appropriate targeted oral antibiotic based on stewardship principles.
Oral amoxicillin is the optimal choice.
Amoxicillin provides excellent, narrow-spectrum coverage for penicillin-susceptible S. pneumoniae. Broad-spectrum agents or beta-lactamase inhibitors are unnecessary and inappropriate.

Key Concept

Patients hospitalized for community-acquired pneumonia should be transitioned from empirical intravenous therapy to targeted, narrow-spectrum oral antibiotics once they demonstrate clinical stability and a susceptible pathogen is identified.
Question 1579Question →

A 45-year-old woman is newly diagnosed with moderate-to-severe, seropositive rheumatoid arthritis. She has no significant past medical history, normal hepatic and renal function, and no contraindications to standard pharmacotherapies. Assuming she requires continuous escalation of therapy due to inadequate responses at each step and ultimately develops severe, end-stage structural damage in her right knee over many years, arrange the following management steps in the correct chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of management is: 1) Initiate conventional synthetic DMARD monotherapy with methotrexate, 2) Add a tumor necrosis factor (TNF) alpha inhibitor, 3) Switch to a biologic DMARD with a different mechanism of action, 4) Refer for surgical total joint arthroplasty.
The standard stepwise approach to rheumatoid arthritis begins with conventional synthetic DMARDs (methotrexate), escalates to a biologic DMARD (often a TNF inhibitor) upon inadequate response, switches to a non-TNF biologic upon subsequent failure, and ultimately relies on surgical joint replacement for irreversible, end-stage structural damage.

Step-by-Step Solution

1
Identify the appropriate first-line therapy for newly diagnosed, moderate-to-severe rheumatoid arthritis.
Methotrexate monotherapy is selected.
Methotrexate is the foundational initial disease-modifying agent due to its well-established long-term efficacy, safety profile, and cost-effectiveness.
2
Determine the next pharmacological step after an inadequate response to initial monotherapy.
Addition of a biologic DMARD (e.g., TNF inhibitor).
Guidelines recommend stepping up therapy by adding a biologic DMARD when disease activity remains unacceptably high despite maximally tolerated methotrexate.
3
Determine the management approach for a patient who fails initial biologic therapy.
Switch to a biologic with a different mechanism of action.
Cycling to a different class of biologic (non-TNF) is generally more effective than trying a second TNF inhibitor in cases of primary primary treatment failure.
4
Address end-stage, irreversible joint destruction.
Referral for total joint arthroplasty.
When pharmacological therapy cannot reverse existing structural damage and the patient suffers from intractable mechanical pain and dysfunction, surgical replacement is indicated.

Key Concept

Stepwise escalation of pharmacotherapy and surgical management in rheumatoid arthritis.
Estimated Time:1m 0s
Question 1580Question →

Match each clinical presentation with its most likely underlying pathophysiological mechanism.

Click a left item, then click its matching right item

Items

A 35-year-old woman with fever, confusion, schistocytes on peripheral smear, and normal coagulation times
A 65-year-old man with massive splenomegaly, fatigue, and teardrop red blood cells on peripheral smear
A 70-year-old man with painless cervical lymphadenopathy, marked lymphocytosis, and smudge cells on smear
A 28-year-old man developing jaundice and dark urine after trimethoprim-sulfamethoxazole use, with bite cells
A 45-year-old woman with recurrent deep vein thromboses, pregnancy losses, and a prolonged PTT

Matches

Show answer & explanation

Answer

Each clinical presentation is matched to its corresponding pathognomonic mechanism.
Each clinical vignette provides pathognomonic clues for a specific hematologic disorder. TTP is caused by ADAMTS13 deficiency; Primary Myelofibrosis involves marrow fibrosis from abnormal megakaryocytes; CLL is a CD5+ B cell neoplasm; G6PD deficiency involves defective generation of reduced glutathione; and Antiphospholipid Syndrome is driven by autoantibodies against phospholipid-binding proteins.

Step-by-Step Solution

1
Analyze the first presentation (fever, confusion, schistocytes, normal PT/PTT)
Diagnose Thrombotic Thrombocytopenic Purpura (TTP)
The combination of microangiopathic hemolytic anemia and thrombocytopenia with normal coagulation parameters points to ADAMTS13 deficiency.
2
Analyze the second presentation (splenomegaly, teardrop cells)
Diagnose Primary Myelofibrosis
Teardrop cells form as red blood cells squeeze through a fibrotic marrow space.
3
Analyze the third presentation (elderly patient, lymphadenopathy, smudge cells)
Diagnose Chronic Lymphocytic Leukemia (CLL)
Smudge cells are fragile neoplastic B cells that rupture easily during blood smear preparation.
4
Analyze the fourth presentation (hemolysis after sulfa drug exposure, bite cells)
Diagnose Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency
Oxidative damage precipitates hemoglobin (Heinz bodies), which splenic macrophages 'bite' out, leading to hemolysis.
5
Analyze the fifth presentation (thrombosis, miscarriages, prolonged PTT)
Diagnose Antiphospholipid Syndrome
Lupus anticoagulant falsely prolongs PTT in vitro, but causes hypercoagulability and thrombosis in vivo.

Key Concept

Pathophysiological mechanisms of classic hematologic and oncologic disorders based on their peripheral smear and clinical presentations.
PreviousPage 79 / 414Next
All practice questions — USMLE Step 2 CK | Examkin